Can a new class of weight loss drugs like Ozempic and Wegovy finally change the way we talk about obesity? vox.com
While celebrities and billionaires praise the weight loss effects of these drugs, regular patients, including those with Type 2 diabetes, struggle with access, raising questions about who will really benefit from treatment. vox.com
But another tension has emerged in this story: The medicines have become a lightning rod in an obesity conversation that is increasingly binary β swinging between fat acceptance and fatphobia. vox.com
Loading suggestions...